CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) shares gapped down prior to trading on Thursday . The stock had previously closed at $48.37, but opened at $46.63. CochLear shares last traded at $46.63, with a volume of 168 shares changing hands.
Wall Street Analyst Weigh In
CHEOY has been the subject of several recent analyst reports. Canaccord Genuity Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Zacks Research raised shares of CochLear from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research note on Thursday, July 16th. Finally, Jefferies Financial Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Six analysts have rated the stock with a Hold rating, According to data from MarketBeat, CochLear has a consensus rating of “Hold” and a consensus price target of $117.00.
Check Out Our Latest Analysis on CHEOY
CochLear Stock Performance
CochLear Company Profile
Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may not receive sufficient benefit from conventional hearing aids.
The company’s portfolio includes cochlear implants, bone conduction hearing implants, and related sound processors, accessories, software and support services. Cochlear also provides rehabilitation resources, clinical support and ongoing product services intended to help recipients use and maintain their hearing systems.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear serves customers through a global network spanning Australia, New Zealand, North America, Europe, Asia and other international markets.
Featured Articles
- Five stocks we like better than CochLear
- Apple Is Quietly Building an AI Advantage Few Expected
- How Serious Is the Regulatory Threat Now Facing Tesla’s Cybercab?
- Can ServisFirst Keep Delivering?
- CoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
